Colin Thomas - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Colin Thomas's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Colin Thomas
Verified
News Director and Anchor, CFQC-TV (Saskatoon, SK)
Saskatoon
Beats
Consumer goods & services
Content
By Omar Elghawy, Jonathan Sussman, Austin Yang, Colin Thomas Verified| JAMA (The Journal of the American Medical Association) Verified Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma (CTCL). Recent clinical trials have investigated immune checkpoint inhibitors (ICIs) as monotherapy or combination therapies for MF/SS with mixed results.1-3 Clinical data for ICIs in CTCL are sparse, limited primarily to case reports or small case series.
By Colin Thomas Verified| The Daily Times (Maryville, TN) Verified State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed...
By Omar Elghawy, Jonathan Sussman, Austin Yang, Colin Thomas Verified| JAMA (The Journal of the American Medical Association) Verified Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma (CTCL). Recent clinical trials have investigated immune checkpoint inhibitors (ICIs) as monotherapy or combination therapies for MF/SS with mixed results.1-3 Clinical data for ICIs in CTCL are sparse, limited primarily to case reports or small case series.
Company Info
CFQC-TV (Saskatoon, SK)